Insights

7/6/2026 9:45:00 PM

USPTO Expands U.S. Patent Counsel Requirements for Foreign Applicants and Patent Owners

By Karthika Perumal Jeffrey Whittle

Beginning July 20, 2026, parties based outside the United States or its territories will need USPTO-registered patent counsel for a broad...

6/17/2026 8:39:00 PM

By Dana Severance Alexander Wharton

The FDA has issued new draft Q&A guidance (available here) on Forms FDA 3542a and FDA 3542, providing additional clarity on Orange Book...

5/18/2026 3:38:44 PM

By Kyle W. Kellar Pete Bromaghim

4/30/2026 7:20:42 PM

By Karthika Perumal Michael Samardzija

4/27/2026 4:31:00 PM

By Constantine Marantidis G. Warren Bleeker Kyle W. Kellar

For much of the past decade, post grant patent practice in the United States was dominated by the post-grant proceedings formed as part...

4/3/2026 6:29:00 PM

By Karthika Perumal Michael Samardzija Jeffrey Whittle

Get inventorship wrong, and a valuable patent can become unenforceable. A patent must accurately name the individuals who invented the...

3/17/2026 4:50:00 PM

By Preston Heard

On March 11, 2026, USPTO Director John A. Squires issued a memorandum introducing new discretionary factors for the institution of inter...

12/9/2025 9:19:00 PM

By Seiko Okada Jeffrey Whittle Samuel Savanich +1 more...

In follow up to the August 4, 2025 guidance and the September 26, 2025 In re Desjardins decision, the USPTO recently took another...

12/17/2020 5:33:00 PM

By Womble Bond Dickinson

On Friday December 11, 2020, the FDA granted Emergency Use Authorization (“EUA”) of the Pfizer-BioNtech COVID-19 vaccine. Approval of...